These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31341419)

  • 41. High-sensitivity C-reactive protein predicts adverse outcomes after non-ST-segment elevation acute coronary syndrome regardless of GRACE risk score, but not after ST-segment elevation myocardial infarction.
    Raposeiras Roubín S; Barreiro Pardal C; Roubín-Camiña F; Ocaranza Sanchez R; Alvarez Castro E; Paradela Dobarro B; García-Acuña JM; Aguiar Souto P; Jacquet Hervet M; Castromán MJ; Arufe I; Outes B; Reino-Maceiras MV; Abu Assi E; González-Juanatey JR
    Rev Port Cardiol; 2013 Feb; 32(2):117-22. PubMed ID: 23337430
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum levels of anti-apolipoprotein A-1 auto-antibodies and myeloperoxidase as predictors of major adverse cardiovascular events after carotid endarterectomy.
    Vuilleumier N; Montecucco F; Spinella G; Pagano S; Bertolotto M; Pane B; Pende A; Galan K; Roux-Lombard P; Combescure C; Dallegri F; Mach F; Palombo D
    Thromb Haemost; 2013 Apr; 109(4):706-15. PubMed ID: 23364307
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current Smoking and Prognosis After Acute ST-Segment Elevation Myocardial Infarction: New Pathophysiological Insights.
    Haig C; Carrick D; Carberry J; Mangion K; Maznyczka A; Wetherall K; McEntegart M; Petrie MC; Eteiba H; Lindsay M; Hood S; Watkins S; Davie A; Mahrous A; Mordi I; Ahmed N; Teng Yue May V; Ford I; Radjenovic A; Welsh P; Sattar N; Oldroyd KG; Berry C
    JACC Cardiovasc Imaging; 2019 Jun; 12(6):993-1003. PubMed ID: 30031700
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Myeloperoxidase (MPO) and interleukin-17 (IL-17) plasma levels are increased in patients with acute coronary syndromes.
    Liang J; Zheng Z; Wang M; Han L; Zheng Z; Peng J; Liu Z; Wei Y
    J Int Med Res; 2009; 37(3):862-6. PubMed ID: 19589271
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic value of cystatin C in patients with acute coronary syndrome: A systematic review and meta-analysis.
    Sun Y; Lu Q; Cheng B; Tao X
    Eur J Clin Invest; 2021 Mar; 51(3):e13440. PubMed ID: 33128232
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of the multiple-biomarker approach for diagnosis of myocardial infarction in patients presenting with symptoms suggestive of acute coronary syndrome.
    Apple FS; Smith SW; Pearce LA; Murakami MM
    Clin Chem; 2009 Jan; 55(1):93-100. PubMed ID: 19028826
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Usefulness of cardiac biomarker score for risk stratification in stable patients undergoing elective cardiac evaluation across glycemic status.
    Tang WH; Iqbal N; Wu Y; Hazen SL
    Am J Cardiol; 2013 Feb; 111(4):465-70. PubMed ID: 23219176
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Myeloperoxidase: a new biomarker of inflammation in ischemic heart disease and acute coronary syndromes.
    Loria V; Dato I; Graziani F; Biasucci LM
    Mediators Inflamm; 2008; 2008():135625. PubMed ID: 18382609
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum myeloperoxidase/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease.
    Haraguchi Y; Toh R; Hasokawa M; Nakajima H; Honjo T; Otsui K; Mori K; Miyamoto-Sasaki M; Shinohara M; Nishimura K; Ishida T; Hirata K
    Atherosclerosis; 2014 Jun; 234(2):288-94. PubMed ID: 24704632
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography.
    Heslop CL; Frohlich JJ; Hill JS
    J Am Coll Cardiol; 2010 Mar; 55(11):1102-9. PubMed ID: 20223364
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HEART Score Risk Stratification of Low-Risk Chest Pain Patients in the Emergency Department: A Systematic Review and Meta-Analysis.
    Laureano-Phillips J; Robinson RD; Aryal S; Blair S; Wilson D; Boyd K; Schrader CD; Zenarosa NR; Wang H
    Ann Emerg Med; 2019 Aug; 74(2):187-203. PubMed ID: 30718010
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Markers of plaque instability in the early diagnosis and risk stratification of acute myocardial infarction.
    Schaub N; Reichlin T; Meune C; Twerenbold R; Haaf P; Hochholzer W; Niederhauser N; Bosshard P; Stelzig C; Freese M; Reiter M; Gea J; Buser A; Mebazaa A; Osswald S; Mueller C
    Clin Chem; 2012 Jan; 58(1):246-56. PubMed ID: 22057876
    [TBL] [Abstract][Full Text] [Related]  

  • 53. B-type natriuretic peptide is a long-term predictor of all-cause mortality, whereas high-sensitive C-reactive protein predicts recurrent short-term troponin T positive cardiac events in chest pain patients: a prognostic study.
    Brügger-Andersen T; Pönitz V; Staines H; Pritchard D; Grundt H; Nilsen DW
    BMC Cardiovasc Disord; 2008 Nov; 8():34. PubMed ID: 19032759
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities.
    Ang DS; Kong CF; Kao MP; Struthers AD
    Am Heart J; 2009 Jul; 158(1):133-40. PubMed ID: 19540403
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Lindberg S; Pedersen SH; Mogelvang R; Jensen JS; Flyvbjerg A; Galatius S; Magnusson NE
    J Am Coll Cardiol; 2012 Jul; 60(4):339-45. PubMed ID: 22813613
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of myeloperoxidase as predictor of systemic inflammatory response syndrome in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention.
    Samimi-Fard S; Dominguez-Rodriguez A; Abreu-Gonzalez P; Enjuanes-Grau C; Blanco-Palacios G; Hernandez-Baldomero IF; Bosa-Ojeda F; Marrero-Rodríguez F
    Am J Cardiol; 2009 Sep; 104(5):634-7. PubMed ID: 19699336
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Growth differentiation factor-15 predicts the prognoses of patients with acute coronary syndrome: a meta-analysis.
    Zhang S; Dai D; Wang X; Zhu H; Jin H; Zhao R; Jiang L; Lu Q; Yi F; Wan X; Cui H
    BMC Cardiovasc Disord; 2016 May; 16():82. PubMed ID: 27154403
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic value of cardiac troponin T after noncardiac surgery: 6-month follow-up data.
    Lopez-Jimenez F; Goldman L; Sacks DB; Thomas EJ; Johnson PA; Cook EF; Lee TH
    J Am Coll Cardiol; 1997 May; 29(6):1241-5. PubMed ID: 9137219
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic value of admission myeloperoxidase levels in patients with ST-segment elevation myocardial infarction and cardiogenic shock.
    Dominguez-Rodriguez A; Samimi-Fard S; Abreu-Gonzalez P; Garcia-Gonzalez MJ; Kaski JC
    Am J Cardiol; 2008 Jun; 101(11):1537-40. PubMed ID: 18489929
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictive value of myeloperoxidase to identify high risk patients admitted to the hospital with acute chest pain.
    Esporcatte R; Rey HC; Rangel FO; Rocha RM; Mendonça Filho HT; Dohmann HF; Albanesi Filho FM
    Arq Bras Cardiol; 2007 Dec; 89(6):377-84. PubMed ID: 18317620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.